https://www.microcapobserver.com/science/moleculin-miracle-aml-interim-remission-dataMicroCap Observeren2026-08-16T08:18:27-04:00Moleculin's AML Trial Shows a Threefold Interim Remission Advantage - But the Definitive Readout Is Still Ahead